H35.5
Hereditary retinal dystrophy
Clinical Classification Guidelines
Excludes Type 1
- dystrophies primarily involving Bruch's membrane (H31.1-)
Medical Intelligence & Overview
Hereditary retinal dystrophy is a group of genetic eye disorders characterized by progressive deterioration of the retina, the light-sensitive layer at the back of the eye. This condition can lead to vision loss over time and often affects individuals who inherit specific gene mutations. Understanding this condition can help patients recognize early symptoms and seek appropriate management to preserve their sight as long as possible.
Causes & Symptoms
Clinical Causes: Genetic mutations passed from parents to children Inheritance patterns vary, including autosomal dominant, autosomal recessive, or X-linked inheritance Multiple genes are associated with different forms of retinal dystrophies, making each case unique Sometimes, the exact cause of the genetic mutation remains unknown
Key Symptoms: Gradual loss of visual acuity Difficulty adapting to low light or night blindness Loss of peripheral vision, leading to tunnel vision Presence of abnormal eye movements Changes in color perception Central or patchy areas of visual field loss
Diagnostic & Treatment
Diagnosis Path: Diagnosing hereditary retinal dystrophy involves a comprehensive eye exam, including visual acuity tests and assessments of color vision. Specialized tests such as optical coherence tomography (OCT), fundus photography, and electroretinography (ERG) help evaluate retina structure and function. A detailed family history is crucial for identifying inheritance patterns. Genetic testing may also be employed to detect specific gene mutations associated with the disorder. Early diagnosis is important for planning management and monitoring disease progression.
Treatment Protocols: Currently, there is no cure for hereditary retinal dystrophy; however, various approaches can help manage symptoms and support vision. These include visual aids like magnifiers, orientation and mobility training, and low-vision devices. Research is ongoing into gene therapy and other innovative treatments that may restore or preserve retinal function in the future. Regular eye evaluations are vital for tracking disease progression and adapting management strategies.
Clinical Advice & FAQs
Billing Guidance
Is H35.5 a billable ICD-10 code?
Yes, H35.5 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report H35.5?
Clinical documentation must specify the nature of Hereditary retinal dystrophy and any associated comorbidities for accurate reporting.
Cite this Clinical Reference